Saxagliptin-<sup>13</sup>C-d<sub>2</sub> (hydro<wbr/>chloride)

Saxagliptin-13C-d2 (hydrochloride)

CAT N°: 26709
Price:

From 604.00 513.40

Saxagliptin-13C-d2 is intended for use as an internal standard for the quantification of saxagliptin (Item No. 23697) by GC- or LC-MS. Saxagliptin is a potent inhibitor of dipeptidyl peptidase 4 (DPP-4; Ki = 0.6 nM).{40437} It inhibits DPP-4 ex vivo (ED50 = 0.12 ?mol/kg) in plasma from normal fasted rats. Saxagliptin (0.3-3 mg/kg) reduces plasma glucose levels in Zuckerfa/fa diabetic rats in a dose-dependent manner. Oral administration at doses ranging from 1-10 ?mol/kg increases plasma insulin levels and improves glucose clearance in ob/ob mice, a transgenic model of obesity. Saxagliptin induces systolic and diastolic dysfunction, reduces contractile force, and exacerbates ischemia-reperfusion injury-induced cardiac dysfunction in isolated guinea pig hearts.{40438} Formulations containing saxagliptin have been used for the treatment of type 2 diabetes.

We also advise you